Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
pharmaceutical, biofuel and chemical production, today announced that
John Nicols, President and CEO of Codexis, will present a ... read more
Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
pharmaceutical, biofuel and chemical production, today announced it will
host a live conference call and audio webcast on ... read more
Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
pharmaceutical, biofuel and chemical production, announced today that
Gjalt Huisman, Ph.D., Vice President, Pharmaceutical R&D at Codexis,
... read more
Strem Chemicals, Inc., a manufacturer of specialty chemicals for
research and development and Codexis, Inc. (NASDAQ: CDXS), a developer
of world-leading enzymes and processes for the production of ... read more
Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading enzymes and
processes for the production of pharmaceuticals, biofuels and bio-based
chemicals, today announced it will host a live conference ... read more